AKT1 and ovarian carcinoma: MiR-214 was a well-known miRNA in drug resistance, which enhanced cell survival and induced cisplatin resistance in ovarian cancer cells by directly downregulating the expression of phosphatase and tensin homolog (PTEN), a negative regulatory molecule of the PI3K/AKT pathway (42).